Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.

التفاصيل البيبلوغرافية
العنوان: Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.
المؤلفون: Skubal M, Larney BM, Phung NB, Desmaras JC, Dozic AV, Volpe A, Ogirala A, Machado CL, Djibankov J, Ponomarev V, Grimm J
المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Aug 08. Date of Electronic Publication: 2023 Aug 08.
نوع المنشور: Preprint
اللغة: English
بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
مستخلص: The cascade of events leading to tumor formation includes induction of a tumor supporting neovasculature as a primary hallmark of cancer. Developing vasculature is difficult to evaluate in vivo but can be captured using microfluidic chip technology and patient derived cells. Herein, we established an on chip approach to investigate the mechanisms promoting tumor vascularization and vascular targeted therapies via co-culture of metastatic renal cell carcinoma spheroids and endothelial cells in a 3D environment. Our model permitted real-time, high-resolution observation and assessment of tumor-induced angiogenesis, where endothelial cells sprout towards the tumor and mimic a vascular network. Bevacizumab, an angiogenic inhibitor, disrupted interactions between vessels and tumors, destroying the vascular network. The on chip approach enabled assessment of endothelial cell biology, vessel's functionality, drug delivery, and molecular expression of PSMA. Finally, observations in the vascularized tumor on chip permitted direct and conclusive quantification of this therapy in weeks as opposed to months in a comparable animal model.
Teaser: Vascularized tumor on microfluidic chip provides opportunity to study targeted therapies and improves preclinical drug discovery.
معلومات مُعتمدة: T32 CA062948 United States CA NCI NIH HHS
تواريخ الأحداث: Date Created: 20230823 Latest Revision: 20240419
رمز التحديث: 20240419
مُعرف محوري في PubMed: PMC10441301
DOI: 10.1101/2023.08.07.552309
PMID: 37609216
قاعدة البيانات: MEDLINE
الوصف
DOI:10.1101/2023.08.07.552309